LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Finance & Accounting Businesses for Sale
Healthcare & Medical Businesses for Sale
Bars, Pubs & Nightclubs for Sale
Startup Investment Opportunities
Environmental Businesses for Sale
Gift & Flower Shops for Sale
Convenience Stores & Lotto Businesses For Sale
Liquor Store Businesses for Sale
Printing, Signs & Publishing Businesses for Sale
Cleaning & Janitorial Businesses for Sale
Gas Station & Car Wash Franchises for Sale
Healthcare & Medical Franchise Opportunities
Pet Franchise Opportunities
Bars & Pubs Franchises for Sale
Construction & Landscaping Franchise Opportunities
Catering Franchise Opportunities
Beauty & Personal Care Franchises for Sale
Automotive Franchises for Sale
Smoke & Vape Shop Franchises for Sale
Warehouse & Storage Franchise for Sale
Industrial Units for Sale or Rent
Houses & Condos for Sale or Lease
Commercial Spaces for Sale or Lease
Office Spaces for Sale or Rent
Retail Buildings for Sale or Lease
Industrial Buildings for Sale or Lease
Medical Buildings for Sale or Lease
Miscellaneous Properties for Sale or Lease
Retail Spaces for Lease or Sale
Land & Developments for Sale
An email will be sent to registered email address.
Please select if you are: